Nucleic Acids ResearchBiochemistryPeer-reviewed journal article
High-throughput competitive binding assay for targeting RNA with small molecules: discovery of new PreQ1 riboswitch ligands
Sophie E.L. WintermansiD, Jana S HoffmanniD, Victor van Kuijk, Yelda Durmus, Mariska D. Tacoma, Indy BroekhuizeniD, Antonius P. A. JansseniD, Hans van den Elst, Bjorn R. van DoodewaerdiD, Paul P. GeurinkiD, Marta ArtolaiD, René C. L. OlsthoorniD
Abstract
In the evolving landscape of RNA targeting, there is an indisputable need for new screening methodologies to find small molecules targeting relevant tertiary RNA structures, like viral pseudoknots or bacterial riboswitches. Here, we developed a competitive binding high-throughput screening assay to identify ligands for the bacterial PreQ1-I riboswitch. In this assay, ligands compete with a rationally designed quencherlabeled antisense for binding to the riboswitch. The method is validated for the Fusobacterium nucleatum (Fnu), Thermoanaerobacter tengcongensis (Tte), Bacillus subtilis (Bsu) and Enterococcus faecalis (Efa) PreQ1 riboswitches, using the natural riboswitch ligand PreQ1 and various analogues. A commercial RNA-focused library consisting of [~]15,000 compounds was then screened against the Fnu riboswitch, leading to the identification of 4 hits exhibiting competitive binding activity. These hits were evaluated in in vitro translation assays against several PreQ1 riboswitches. The most promising hit 4494 showed competitive binding activity to the Fnu, Tte, Bsu and Efa riboswitches, and was able to inhibit translation of a Tte riboswitch-regulated reporter gene, making it an interesting starting point for the development of new antibiotics. In essence, this HTS assay has the potential to discover highly sought-after RNA targeting small molecules for complex and clinically relevant RNA structures. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC="FIGDIR/small/595132v1_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@d7af01org.highwire.dtl.DTLVardef@227e93org.highwire.dtl.DTLVardef@a3f24corg.highwire.dtl.DTLVardef@17883e9_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: bacteria (other)
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 4
- FWCI
- 0.96
- Field percentile
- top 28%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protein-based Virtual Screening Tools applied for RNA-Ligand Docking identify new Binders of the preQ1-Riboswitch
Elisabeth Kallert, Tim R. Fischer, … Christian Kersten·Journal of Chemical Information and ModelingPeer-reviewed·Aug 22, 2022
- Mechanistic Analysis of Riboswitch Ligand Interactions Provides Insights into Pharmacological Control over Gene Expression
S. Parmar, D. D. Bume, … J. S. Schneekloth·bioRxiv·Feb 23, 2024
- Binding Free energy Decomposition and Multiple Unbinding Paths of Buried Ligands in a PreQ1 Riboswitch
G. Hu, H.-X. Zhou·bioRxiv·Jul 13, 2021
- SHAPE-based chemical probes for studying preQ1-RNA interactions in living bacteria
José A. Reyes Franceschi, Emilio L. Cárdenas, … Amanda L. Garner·ACS Chemical BiologyPeer-reviewed·Oct 10, 2025
- Targeting riboswitches with beta-axial substituted cobalamins
S. R. Lennon, A. J. Wierzba, … R. T. Batey·bioRxiv·Dec 25, 2022
- Conformational and molecular interactions of small molecules targeting the SAM-I riboswitch
Vrinda Nair, Mohammadreza Niknam Hamidabad, … Rachael A. Mansbach·bioRxiv·Mar 27, 2026